Clotrimazole

CHEMBL104 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
344.8 g/mol
LogP
5.0
Phase
4

A broad-spectrum azole antifungal that disrupts fungal cell membranes by inhibiting ergosterol synthesis, used to treat athlete's foot, vaginal yeast infections, and oral thrush. It is available as creams, lozenges, and vaginal suppositories.

分子量

344.8000 g/mol

LogP

5.00

TPSA

17.80 Ų

リピンスキーの五則

適合

治療領域

作用機序

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1

InChI

InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H

Molecular Formula

C22H17ClN2

HBD / HBA

- / 1

回転可能結合数

4

重原子数

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A broad-spectrum azole antifungal that disrupts fungal cell membranes by inhibiting ergosterol synthesis, used to treat athlete's foot, vaginal yeast infections, and oral thrush. It is available as creams, lozenges, and vaginal suppositories.

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Yes, Clotrimazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL104. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2812. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.